CURX Curanex Pharmaceuticals Inc

CIK 0002025942 10 ready 8-Ks latest May 14, 2026, 9:15 AM ET RSS · JSON

Activity: QUIET 0 filings / 30d vs 1 baseline

Ready 8-Ks 10

Latest filing May 14, 2026, 9:15 AM ET

Top materiality 0.85

Event mix other_material ×6 · regulatory ×2 · leadership ×2

Sentiment 4 pos · 2 neg · 4 neu

SHENANIGAN SCORE 2 / 7 see the board

Recent 8-K filings for CURX

Highest-materiality recent filing

Curanex Pharmaceuticals prices IPO of 3.75M shares at $4.00/share, gross $15M

August 26, 2025, 7:59 PM ET other material materiality 0.85 positive item 1.01 item 8.01 item 9.01

Gross proceeds $15M from 3.75M shares at $4.00/share; net proceeds ~$12.1M after underwriting discounts and expenses.
Shares expected to begin trading on Nasdaq (CURX) on Aug 26, 2025; close expected Aug 27, 2025.

May 14, 2026, 9:15 AM ET other material materiality 0.60 positive item 7.01 item 9.01

Curanex completes key Phyto-N milestones; plans Q4 2026 IND for ulcerative colitis

Completed GMP pilot-scale batch of Phyto-N in February 2026 to support IND-enabling studies.
November 6, 2025, 6:59 PM ET regulatory materiality 0.70 negative item 3.01 ◈ Listing & Compliance Notices

Curanex Pharmaceuticals receives Nasdaq bid price deficiency notice; 180-day cure period

Received Nasdaq notice on Nov 5, 2025 for bid price below $1.00 for 30 consecutive days.
August 27, 2025, 7:59 PM ET other material materiality 0.70 neutral item 8.01 item 9.01

Curanex Pharmaceuticals closes IPO of 3.75M shares at $4.00, raising $15M gross

Gross proceeds of $15M from IPO of 3,750,000 shares at $4.00 per share on firm commitment basis.
August 26, 2025, 7:59 PM ET other material materiality 0.85 positive item 1.01 item 8.01 item 9.01

Curanex Pharmaceuticals prices IPO of 3.75M shares at $4.00/share, gross $15M

Gross proceeds $15M from 3.75M shares at $4.00/share; net proceeds ~$12.1M after underwriting discounts and expenses.

Max materiality 0.85 · Median 0.55 · Most common event other_material

4 positive 2 negative 4 neutral